Jacobs Levy Equity Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-594,108
Closed -$255K 1066
2022
Q3
$255K Buy
+594,108
New +$584K ﹤0.01% 911
2021
Q2
Sell
-258,662
Closed -$843K 1144
2021
Q1
$843K Sell
258,662
-527,593
-67% -$1.89M 0.01% 779
2020
Q4
$2.68M Sell
786,255
-313,440
-29% -$1.29M 0.02% 514
2020
Q3
$4.49M Buy
1,099,695
+241,448
+28% +$918K 0.05% 368
2020
Q2
$2.9M Buy
858,247
+602,162
+235% +$1.75M 0.03% 453
2020
Q1
$597K Sell
256,085
-45,789
-15% -$125K 0.01% 723
2019
Q4
$1.1M Buy
+301,874
New +$2.44M 0.01% 675
2017
Q3
Sell
-117,647
Closed -$876K 1031
2017
Q2
$876K Sell
117,647
-95,600
-45% -$625K 0.02% 591
2017
Q1
$1.39M Buy
213,247
+168,947
+381% +$945K 0.03% 488
2016
Q4
$196K Buy
+44,300
New +$186K ﹤0.01% 837
2016
Q3
Sell
-237,901
Closed -$1.56M 1162
2016
Q2
$1.56M Buy
237,901
+186,361
+362% +$1.32M 0.03% 480
2016
Q1
$328K Buy
51,540
+35,740
+226% +$183K 0.01% 842
2015
Q4
$95K Buy
15,800
+4,200
+36% +$24K ﹤0.01% 744
2015
Q3
$69K Buy
+11,600
New +$80.5K ﹤0.01% 780
2013
Q3
Sell
-22,600
Closed -$169K 1041
2013
Q2
$169K Buy
+22,600
New +$173K ﹤0.01% 913

Other funds holding SPPI

Jacobs Levy Equity Management's SPPI Position: Q4 2022 in Review

Jacobs Levy Equity Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2022, closing a stake of 594,108 shares — an estimated $255K sold.

Jacobs Levy Equity Management first reported a position in SPPI in Q2 2013 and held it in 15 quarters. The position peaked at $4.49M in Q3 2020. 70 funds tracked by Wall St. Rank hold SPPI as of Q4 2022.

  • Jacobs Levy Equity Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2022 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 594,108 Spectrum Pharmaceuticals Inc shares in Q4 2022, an estimated $255K.
  • Jacobs Levy Equity Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Jacobs Levy Equity Management's Spectrum Pharmaceuticals Inc position peaked at $4.49M in Q3 2020.
  • 70 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.